Astrazeneca (AZN) closed at $188.42 in the latest trading session, marking a +2.74% move from the prior day. The stock's change was more than the S&P 500's daily loss of 1.67%. Meanwhile, the Dow ...

Tuesday, April 7, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily ...

In addition to J.P. Morgan, AstraZeneca also received a Buy from Barclays’s James Gordon CFA in a report issued today. However, yesterday, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: ...

AstraZeneca AZN is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 4.39% ...

AstraZeneca has delivered a solid trailing 12 months, with shares up 31.43% over the past year, but the stock has pulled back nearly 5% over the past month.

In a report released today, Michael Leuchten from Jefferies maintained a Buy rating on AstraZeneca, with a price target of £180.00.

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the personal finance news from the world of business including BSE ...

Astrazeneca (AZN) closed the most recent trading day at $203.49, moving +1.37% from the previous trading session. This change outpaced the S&P 500's 0.11% gain on the day. Meanwhile, the Dow ...

On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner at Cerity Partners, named AstraZeneca PLC (NASDAQ:AZN) as his final trade. On Aug. 20, AstraZeneca released complete results from the ...